A double-blind placebo-controlled study to evaluate endometrial safety and gynaecological symptoms in women treated for up to 5 years with tamoxifen or placebo - a substudy for IBIS I Breast Cancer Prevention Trial

Tiina Palva; Hannu Ranta; Anna-Maija Koivisto; Liisa Pylkkänen; Jack Cuzick; Kaija Holli

doi:10.1016/j.ejca.2012.06.015

A double-blind placebo-controlled study to evaluate endometrial safety and gynaecological symptoms in women treated for up to 5 years with tamoxifen or placebo - a substudy for IBIS I Breast Cancer Prevention Trial

Tiina Palva
, Hannu Ranta
, Anna-Maija Koivisto
, Liisa Pylkkänen
, Jack Cuzick
, Kaija Holli

Research output: Contribution to journal › Article › Scientific › peer-review

13 Citations (Scopus)

Original language	English
Pages (from-to)	4551
Journal	European Journal of Cancer
Volume	49
Issue number	1
DOIs	https://doi.org/10.1016/j.ejca.2012.06.015
Publication status	Published - 2013
Publication type	A1 Journal article-refereed

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Breast cancer prevention
Endometrial safety
Gynaecological symptoms
Tamoxifen

Publication forum classification

Publication forum level 2

Access to Document

10.1016/j.ejca.2012.06.015

Cite this

Palva, T., Ranta, H., Koivisto, A.-M., Pylkkänen, L., Cuzick, J., & Holli, K. (2013). A double-blind placebo-controlled study to evaluate endometrial safety and gynaecological symptoms in women treated for up to 5 years with tamoxifen or placebo - a substudy for IBIS I Breast Cancer Prevention Trial. European Journal of Cancer, 49(1), 4551. https://doi.org/10.1016/j.ejca.2012.06.015

@article{53531499f945446eb42904820780b8ca,

title = "A double-blind placebo-controlled study to evaluate endometrial safety and gynaecological symptoms in women treated for up to 5 years with tamoxifen or placebo - a substudy for IBIS I Breast Cancer Prevention Trial",

keywords = "Breast cancer prevention, Endometrial safety, Gynaecological symptoms, Tamoxifen, Breast cancer prevention, Endometrial safety, Gynaecological symptoms, Tamoxifen",

author = "Tiina Palva and Hannu Ranta and Anna-Maija Koivisto and Liisa Pylkk{\"a}nen and Jack Cuzick and Kaija Holli",

year = "2013",

doi = "10.1016/j.ejca.2012.06.015",

language = "English",

volume = "49",

pages = "4551",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Limited",

number = "1",

}

Palva, T, Ranta, H, Koivisto, A-M, Pylkkänen, L, Cuzick, J & Holli, K 2013, 'A double-blind placebo-controlled study to evaluate endometrial safety and gynaecological symptoms in women treated for up to 5 years with tamoxifen or placebo - a substudy for IBIS I Breast Cancer Prevention Trial', European Journal of Cancer, vol. 49, no. 1, pp. 4551. https://doi.org/10.1016/j.ejca.2012.06.015

A double-blind placebo-controlled study to evaluate endometrial safety and gynaecological symptoms in women treated for up to 5 years with tamoxifen or placebo - a substudy for IBIS I Breast Cancer Prevention Trial. / Palva, Tiina; Ranta, Hannu; Koivisto, Anna-Maija et al.
In: European Journal of Cancer, Vol. 49, No. 1, 2013, p. 4551.

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - A double-blind placebo-controlled study to evaluate endometrial safety and gynaecological symptoms in women treated for up to 5 years with tamoxifen or placebo - a substudy for IBIS I Breast Cancer Prevention Trial

AU - Palva, Tiina

AU - Ranta, Hannu

AU - Koivisto, Anna-Maija

AU - Pylkkänen, Liisa

AU - Cuzick, Jack

AU - Holli, Kaija

PY - 2013

Y1 - 2013

KW - Breast cancer prevention

KW - Endometrial safety

KW - Gynaecological symptoms

KW - Tamoxifen

KW - Breast cancer prevention

KW - Endometrial safety

KW - Gynaecological symptoms

KW - Tamoxifen

U2 - 10.1016/j.ejca.2012.06.015

DO - 10.1016/j.ejca.2012.06.015

M3 - Article

SN - 0959-8049

VL - 49

SP - 4551

JO - European Journal of Cancer

JF - European Journal of Cancer

IS - 1

ER -